A 2 Week Study of Topical KD7040 in the Treatment of Postherpetic Neuralgia (PHN)

NCT00576108 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Postherpetic Neuralgia
Shingles
Herpes Zoster
Neuropathic Pain

Interventions

DRUG: KD7040 Topical Gel
DRUG: Placebo gel

Sponsor

Kalypsys, Inc.